About Specialties Pricing Loading...

Copyright © 2024 Trephine. All rights reserved. The content of this site is intended for health care professionals.

TREPHINE

Terms Of Use Privacy Policy

CirculationLetter

06 May 2025

Response by Bortolin and Pu to Letter Regarding Article, "Antisense Oligonucleotide Therapy for Calmodulinopathy".

No abstract available

COI Statement

None.

Article info

Journal issue:

Volume: 151
Issue: 18

Doi:

10.1161/CIRCULATIONAHA.125.073965

More resources:

Atypon

Full Text Sources

Share: